175 Shares in Danaher Co. (NYSE:DHR) Acquired by Accredited Wealth Management LLC

Accredited Wealth Management LLC purchased a new stake in Danaher Co. (NYSE:DHR) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 175 shares of the conglomerate’s stock, valued at approximately $40,000.

Other institutional investors have also modified their holdings of the company. Norges Bank purchased a new position in shares of Danaher in the 4th quarter valued at about $2,130,740,000. Raymond James Financial Inc. acquired a new stake in Danaher in the fourth quarter valued at approximately $391,172,000. Capital World Investors lifted its stake in Danaher by 32.7% in the fourth quarter. Capital World Investors now owns 6,361,183 shares of the conglomerate’s stock worth $1,460,215,000 after acquiring an additional 1,566,658 shares during the last quarter. Northern Trust Corp grew its holdings in Danaher by 14.3% during the 4th quarter. Northern Trust Corp now owns 7,934,991 shares of the conglomerate’s stock worth $1,821,477,000 after acquiring an additional 992,594 shares in the last quarter. Finally, Van ECK Associates Corp increased its position in shares of Danaher by 6,862.7% in the 4th quarter. Van ECK Associates Corp now owns 929,868 shares of the conglomerate’s stock valued at $213,452,000 after purchasing an additional 916,513 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of DHR stock opened at $199.15 on Friday. Danaher Co. has a 52-week low of $171.00 and a 52-week high of $281.70. The stock’s 50-day moving average price is $199.78 and its 200 day moving average price is $221.78. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The stock has a market capitalization of $142.53 billion, a PE ratio of 37.72, a price-to-earnings-growth ratio of 2.66 and a beta of 0.80.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, topping the consensus estimate of $1.62 by $0.26. Danaher had a return on equity of 10.82% and a net margin of 16.33%. The business had revenue of $5.74 billion during the quarter, compared to analysts’ expectations of $5.58 billion. As a group, equities research analysts forecast that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, April 25th. Stockholders of record on Friday, March 28th were issued a $0.32 dividend. This is an increase from Danaher’s previous quarterly dividend of $0.27. The ex-dividend date was Friday, March 28th. This represents a $1.28 annualized dividend and a dividend yield of 0.64%. Danaher’s payout ratio is presently 24.85%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on DHR shares. The Goldman Sachs Group decreased their price objective on shares of Danaher from $260.00 to $240.00 and set a “neutral” rating for the company in a research report on Wednesday, April 23rd. Raymond James reaffirmed a “market perform” rating on shares of Danaher in a research report on Monday, February 3rd. JPMorgan Chase & Co. cut their target price on Danaher from $280.00 to $260.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 22nd. Guggenheim reaffirmed a “buy” rating and issued a $250.00 price target on shares of Danaher in a report on Wednesday, April 23rd. Finally, Robert W. Baird cut their price objective on shares of Danaher from $231.00 to $225.00 and set an “outperform” rating on the stock in a report on Wednesday, April 23rd. Five equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $264.40.

Insider Buying and Selling

In other Danaher news, EVP Christopher Paul Riley sold 15,805 shares of the stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the transaction, the executive vice president now owns 15,179 shares in the company, valued at approximately $3,005,442. This represents a 51.01 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 11.10% of the stock is currently owned by corporate insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.